Elkhorn Investments LLC raised its position in Danaher Corporation (NYSE:DHR) by 1.8% in the 2nd quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 15,483 shares of the conglomerate’s stock after acquiring an additional 267 shares during the period. Elkhorn Investments LLC’s holdings in Danaher Corporation were worth $1,254,000 as of its most recent SEC filing.

A number of other institutional investors have also recently bought and sold shares of the business. Vanguard Group Inc. raised its holdings in Danaher Corporation by 1.3% in the 2nd quarter. Vanguard Group Inc. now owns 41,488,407 shares of the conglomerate’s stock valued at $3,501,206,000 after acquiring an additional 520,776 shares in the last quarter. BlackRock Inc. raised its holdings in Danaher Corporation by 3.2% in the 2nd quarter. BlackRock Inc. now owns 39,201,798 shares of the conglomerate’s stock valued at $3,308,239,000 after acquiring an additional 1,233,876 shares in the last quarter. FMR LLC raised its holdings in Danaher Corporation by 0.9% in the 2nd quarter. FMR LLC now owns 19,624,350 shares of the conglomerate’s stock valued at $1,656,100,000 after acquiring an additional 183,183 shares in the last quarter. Geode Capital Management LLC raised its holdings in Danaher Corporation by 6.0% in the 1st quarter. Geode Capital Management LLC now owns 5,815,659 shares of the conglomerate’s stock valued at $496,687,000 after acquiring an additional 329,458 shares in the last quarter. Finally, Flossbach Von Storch AG raised its holdings in Danaher Corporation by 44.7% in the 2nd quarter. Flossbach Von Storch AG now owns 5,782,019 shares of the conglomerate’s stock valued at $487,945,000 after acquiring an additional 1,785,810 shares in the last quarter. 75.66% of the stock is owned by hedge funds and other institutional investors.

Several equities analysts have commented on the company. Wells Fargo & Company reaffirmed a “market perform” rating on shares of Danaher Corporation in a report on Saturday, July 22nd. Cowen and Company reaffirmed a “buy” rating and issued a $90.00 price target on shares of Danaher Corporation in a report on Wednesday, October 4th. Jefferies Group LLC reaffirmed a “buy” rating and issued a $95.00 price target on shares of Danaher Corporation in a report on Friday, August 4th. BidaskClub cut Danaher Corporation from a “hold” rating to a “sell” rating in a report on Tuesday, July 25th. Finally, Morgan Stanley reaffirmed an “overweight” rating and issued a $95.00 price target (up previously from $86.00) on shares of Danaher Corporation in a report on Friday, October 6th. One investment analyst has rated the stock with a sell rating, four have issued a hold rating, thirteen have assigned a buy rating and one has assigned a strong buy rating to the company’s stock. Danaher Corporation has a consensus rating of “Buy” and a consensus price target of $93.31.

WARNING: “Elkhorn Investments LLC Purchases 267 Shares of Danaher Corporation (DHR)” was posted by The Cerbat Gem and is owned by of The Cerbat Gem. If you are accessing this article on another domain, it was illegally copied and republished in violation of international trademark & copyright law. The legal version of this article can be accessed at https://www.thecerbatgem.com/2017/10/24/elkhorn-investments-llc-purchases-267-shares-of-danaher-corporation-dhr.html.

In other Danaher Corporation news, insider William King sold 43,688 shares of the business’s stock in a transaction that occurred on Thursday, August 31st. The shares were sold at an average price of $82.86, for a total transaction of $3,619,987.68. Following the completion of the transaction, the insider now directly owns 45,748 shares in the company, valued at $3,790,679.28. The sale was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, insider Thomas Patrick Joyce, Jr. sold 9,772 shares of the business’s stock in a transaction that occurred on Monday, July 31st. The shares were sold at an average price of $81.78, for a total transaction of $799,154.16. Following the transaction, the insider now owns 155,520 shares of the company’s stock, valued at $12,718,425.60. The disclosure for this sale can be found here. 12.20% of the stock is owned by insiders.

Shares of Danaher Corporation (NYSE:DHR) opened at 90.47 on Tuesday. Danaher Corporation has a 52-week low of $76.27 and a 52-week high of $91.72. The company’s 50-day moving average price is $86.80 and its 200-day moving average price is $84.30. The company has a market capitalization of $62.85 billion, a price-to-earnings ratio of 28.88 and a beta of 1.03.

Danaher Corporation (NYSE:DHR) last announced its quarterly earnings data on Thursday, October 19th. The conglomerate reported $1.00 EPS for the quarter, beating the consensus estimate of $0.95 by $0.05. Danaher Corporation had a net margin of 13.36% and a return on equity of 11.29%. The business had revenue of $4.53 billion during the quarter, compared to the consensus estimate of $4.47 billion. During the same period in the previous year, the business earned $0.87 earnings per share. The company’s revenue was up 9.6% on a year-over-year basis. Equities research analysts forecast that Danaher Corporation will post $3.99 EPS for the current fiscal year.

The company also recently disclosed a quarterly dividend, which will be paid on Friday, October 27th. Shareholders of record on Friday, September 29th will be given a dividend of $0.14 per share. The ex-dividend date is Thursday, September 28th. This represents a $0.56 annualized dividend and a yield of 0.62%. Danaher Corporation’s dividend payout ratio is currently 16.52%.

Danaher Corporation Profile

Danaher Corporation (Danaher) designs, manufactures and markets professional, medical, industrial and commercial products and services. The Company operates through four segments: Life Sciences, which offers a range of research tools that scientists use to study the basic building blocks of life, including genes, proteins, metabolites and cells, in order to understand the causes of disease, identify new therapies and test new drugs and vaccines; Diagnostics; which offers analytical instruments, reagents, consumables, software and services; Dental, which provides products that are used to diagnose, treat and prevent disease and ailments of the teeth, gums and supporting bone, and Environmental & Applied Solutions, which consists of various lines of business, including water quality and product identification.

Want to see what other hedge funds are holding DHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Danaher Corporation (NYSE:DHR).

Institutional Ownership by Quarter for Danaher Corporation (NYSE:DHR)

Receive News & Stock Ratings for Danaher Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher Corporation and related stocks with our FREE daily email newsletter.